|
Volumn 15, Issue 3, 2001, Pages 162-165
|
An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients
|
Author keywords
Alzheimer disease; Betaine; Clinical trial; Homocysteine
|
Indexed keywords
BETAINE;
COBALAMIN;
DONEPEZIL;
FOLIC ACID;
HOMOCYSTEINE;
METHIONINE;
METHYL GROUP;
S ADENOSYLMETHIONINE;
ADULT;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DELUSION;
DIARRHEA;
DISEASE COURSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HYPERHOMOCYSTEINEMIA;
IRRITABILITY;
MALE;
PILOT STUDY;
PRIORITY JOURNAL;
PROSTATITIS;
RISK FACTOR;
ADMINISTRATION, ORAL;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
BETAINE;
COGNITION DISORDERS;
DISEASE PROGRESSION;
FEMALE;
GASTROINTESTINAL AGENTS;
HOMOCYSTEINE;
HUMANS;
MALE;
MENTAL STATUS SCHEDULE;
MIDDLE AGED;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 0034861499
PISSN: 08930341
EISSN: None
Source Type: Journal
DOI: 10.1097/00002093-200107000-00008 Document Type: Article |
Times cited : (28)
|
References (21)
|